1st Quarter - Report
DENNY MILLER ASSOCIATES for CELL THERAPEUTICS
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription Drug User Fee Act Reauthorization (no number), provisions relating to approval of new drugs. H.R. 4132 - Faster Access to Specialized Treatments Act, all sections; S. 2113 Transforming the Regulator Environment to Accelerate Access to Treatments, all sections.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDSON GREIF | — |
Medical/Disease Research/Clinical Labs MED
FDA appeal process for new drug applications. Prescription Drug and User Fee Act Reauthorization (no number), provisions relating to approval of new drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDSON GREIF | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.